BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/1/2014 8:25:00 PM | Browse: 1350 | Download: 1489
 |
Received |
|
2014-03-01 11:21 |
 |
Peer-Review Started |
|
2014-03-01 18:36 |
 |
To Make the First Decision |
|
2014-04-15 20:06 |
 |
Return for Revision |
|
2014-04-27 12:24 |
 |
Revised |
|
2014-04-28 00:00 |
 |
Second Decision |
|
2014-05-26 16:28 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-05-26 16:56 |
 |
Articles in Press |
|
2014-05-26 17:31 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-05-29 23:55 |
 |
Typeset the Manuscript |
|
2014-09-12 16:41 |
 |
Publish the Manuscript Online |
|
2014-10-01 20:25 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Contribution of TLR signaling to the pathogenesis of colitis-associated cancer in inflammatory bowel disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ferenc Sipos, István Fűri, Miklós Constantinovits, Zsolt Tulassay and Györgyi Műzes |
Funding Agency and Grant Number |
|
Corresponding Author |
Györgyi Műzes, MD, CSc, PhD, 2nd Department of Internal Medicine, Semmelweis University, Szentkirályi Street 46, 1088 Budapest, Hungary. muzes.gyorgyi@med.semmelweis-univ.hu |
Key Words |
Inflammation; Tissue repair; Immunoregulation; Colitis-associated cancer; Toll-like receptor; Inflammatory bowel disease; Carcinogenesis |
Core Tip |
Colorectal cancers arising in inflammatory bowel disease patients are considered typical examples of inflammation-associated cancers. The exact role of Toll-like receptor (TLR)-signaling in colitis-associated cancer initiation and development is conflicting. Here we aimed to summarize recent data on the contribution of TLR-mediated immune responses to inflamation-related colonic carcinogenesis. |
Publish Date |
2014-10-01 20:25 |
Citation |
Sipos F, Fűri I, Constantinovits M, Tulassay Z, Műzes G. Contribution of TLR signaling to the pathogenesis of colitis-associated cancer in inflammatory bowel disease. World J Gastroenterol 2014; 20(36): 12713-12721 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i36/12713.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i36.12713 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345